Millennium Management’s Maravai LifeSciences MRVI Stock Holding History

Millennium Management’s Portfolio MRVI Stock Details MRVI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-60,000	Closed	-$520K	–	6300
2024 Q1	$520K	Sell	60,000 -160,300	-73%	-$1.08M	﹤0.01%	4782
2023 Q4	$1.44M	Buy	220,300 +100,300	+84%	+$648K	﹤0.01%	3861
2023 Q3	$1.2M	Buy	120,000 +25,000	+26%	+$275K	﹤0.01%	4040
2023 Q2	$1.18M	Buy	+95,000	New	+$1.28M	﹤0.01%	3919
2023 Q1	–	Sell	-30,000	Closed	-$429K	–	6670
2022 Q4	$429K	Sell	30,000 -63,800	-68%	-$1M	﹤0.01%	4849
2022 Q3	$2.4M	Buy	93,800 +13,800	+17%	+$346K	﹤0.01%	3587
2022 Q2	$2.27M	Buy	+80,000	New	+$2.53M	﹤0.01%	3566

Other funds holding MRVI

GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

1WCM

12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return

MAM

Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Millennium Management's MRVI Position: Q1 2026 in Review

Millennium Management reduced its Maravai LifeSciences (MRVI) stake by 8.2% in Q1 2026, selling an estimated $500K and leaving 1,649,490 shares worth $4.67M. The position accounts for ﹤0.01% of the portfolio, ranked #3021.

Millennium Management first reported a position in MRVI in Q4 2020 and has held it in 22 quarters since. The position peaked at $45.9M in Q3 2022. 158 funds tracked by Wall St. Rank hold MRVI as of Q1 2026.

Millennium Management held 1,649,490 shares of Maravai LifeSciences worth $4.67M as of Q1 2026.
Millennium Management sold 147,562 Maravai LifeSciences shares in Q1 2026, an estimated $500K.
Maravai LifeSciences made up ﹤0.01% of Millennium Management's portfolio in Q1 2026, its #3021 holding.
Millennium Management first reported a position in Maravai LifeSciences in Q4 2020 and has held it in 22 quarters since.
Millennium Management's Maravai LifeSciences position peaked at $45.9M in Q3 2022.
158 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.